Pharmacologic Normalization of Altered Transcriptome of SF3B1 Mutant Myeloid Neoplasia
Valeria Visconte(Cleveland Clinic), Jaroslaw P. Maciejewski(Cleveland Clinic), Daniel J. Lindner(Cleveland Clinic), Hetty E. Carraway(Cleveland Clinic), Jennifer S. Carew(University of Arizona), Bartlomiej Przychodzen(Cleveland Clinic), Drew Adams(University School), Christina Snider(Vanderbilt University Medical Center), Yvonne Parker(Cleveland Clinic), Anand D. Tiwari(Cleveland Clinic), Kevin R. Kelly(Keck Hospital of USC), Allison Noe(Cleveland Clinic), James G. Phillips(Auckland University of Technology), Mikkael A. Sekeres(University of Miami), Steffan T. Nawrocki(University of Arizona), Heesun J. Rogers(Cleveland Clinic), Rachel Toth(University of Dundee), Vera Ademà(Cleveland Clinic), Cassandra M Kerr(Cleveland Clinic), Anjali S. Advani(Cleveland Clinic), Yuriy Fedorov(Case Western Reserve University), Hassan Awada(Cleveland Clinic)
Cited by 0
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782